25 Apr 2013

Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans. (Biosci Trends., abstract, edited)

[Source: US National Library of Medicine, full text: (LINK). Abstract, edited.]

Biosci Trends. 2013 Apr;7(2):64-76.

Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.

Mei L, Song PP, Tang Q, Shan K, Tobe RG, Selotlegeng L, Ali AH, Cheng YY, Xu LZ.

Source: Department of Health Care Management and Maternal and Child Health, Shandong University, Ji'nan, Shandong, China.

 

Abstract

The purpose of this review is to provide a reference for the future prevention and control of emerging infectious diseases by summarizing the control strategies, the status of drugs and vaccines, and shortcomings during three major outbreaks of avian influenza among humans (H5N1 in 2003, H1N1 in 2009, and H7N9 in 2013). Data on and documents regarding the three influenza outbreaks have been reviewed. Results indicated that the response to pandemic influenza outbreaks has improved markedly in terms of control strategies, stockpiles of antivirals, and vaccine development. These improvements also suggest advances in disease surveillance, transparency in reporting, and regional collaboration and cooperation. These trends also foreshadow better prospects for prevention and control of emerging infectious diseases. However, there are shortcomings since strategies failed to focus on high-risk groups, quantitative and measurable results (both direct and indirect) were unclear, and quantitative assessment is still lacking.

PMID: 23612075 [PubMed - in process]

-

------